Clinical Report: Visibility of Pulmonary Nodules on Two Ultra-High Resolution CT Scanners

Overview

This phantom study compared pulmonary nodule detectability between ultra-high-resolution photon-counting CT (UHR-PCCT) and energy-integrating detector CT (UHR-EID-CT) systems at clinically relevant dose levels. The UHR-PCCT demonstrated improved spatial resolution and noise characteristics, potentially enhancing small nodule visualization at low and ultra-low dose settings.

Background

Chest CT is the standard imaging modality for pulmonary disease evaluation and lung cancer screening. Low-dose CT protocols reduce radiation exposure but can degrade image quality, impacting small nodule detection. Ultra-high-resolution CT systems with smaller detectors and advanced reconstruction algorithms, including deep learning-based reconstruction, aim to improve spatial resolution and noise reduction. Photon-counting CT technology further enhances dose efficiency and spatial resolution, but direct comparisons with conventional UHR-EID-CT systems for nodule detection are limited.

Data Highlights

Key Findings

• UHR-PCCT provided higher spatial resolution with smaller voxel size (0.2 mm) compared to UHR-EID-CT (0.25 mm).
• Noise power spectrum (NPS) analysis showed improved noise texture and reduced electronic noise with PCCT technology.
• Deep learning-based reconstruction (DLR) algorithms enhanced noise reduction while preserving anatomical detail on both systems.
• At low-dose (2.5 mGy) and ultra-low-dose (0.4 mGy) levels, UHR-PCCT maintained better image quality and nodule detectability than UHR-EID-CT.
• Phantom studies demonstrated improved visualization of 5 mm nodules with varying densities on UHR-PCCT, suggesting potential clinical benefits in lung cancer screening.

Clinical Implications

The improved spatial resolution and noise characteristics of UHR-PCCT may enhance detection and characterization of small pulmonary nodules, particularly at low and ultra-low radiation doses. Incorporating photon-counting CT technology with advanced reconstruction algorithms could optimize lung cancer screening protocols by balancing dose reduction and diagnostic performance. Clinicians should consider these technological advances when selecting CT systems for pulmonary imaging.

Conclusion

This initial phantom study indicates that UHR-PCCT outperforms conventional UHR-EID-CT in pulmonary nodule visibility at clinically relevant dose levels. These findings support further clinical evaluation of photon-counting CT for improved lung cancer screening and diagnosis.

References

1. European Society of Thoracic Imaging Recommendations 2023 -- Low-dose and ultra-low-dose CT protocols
2. Siemens Healthineers 2022 -- Photon-counting CT Technology Overview
3. Canon Medical Systems 2021 -- Aquilion Precision UHR-CT System Specifications
4. Sun Nuclear Mercury Phantom v4.0 -- Phantom for CT Image Quality Assessment
5. Kyoto Kagaku LUNGMAN Phantom -- Anthropomorphic Chest Phantom for Nodule Detection